HMOX1 and COVID-19: An increase in the red cell distribution width, as a marker of hemolysis [20], and a decrease in serum haptoglobin (Hp) were found in patients with severe COVID-19 [21], as well as a significant increase in HO-1 expression in the plasma of severely ill patients with COVID-19 [22].